293 related articles for article (PubMed ID: 33218679)
61. Stearoyl-CoA desaturase 1 deficiency reduces lipid accumulation in the heart by activating lipolysis independently of peroxisome proliferator-activated receptor α.
Bednarski T; Olichwier A; Opasinska A; Pyrkowska A; Gan AM; Ntambi JM; Dobrzyn P
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2029-2037. PubMed ID: 27751891
[TBL] [Abstract][Full Text] [Related]
62. Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule.
Zhang Y; Zhang X; Chen L; Wu J; Su D; Lu WJ; Hwang MT; Yang G; Li S; Wei M; Davis L; Breyer MD; Guan Y
Am J Physiol Renal Physiol; 2006 May; 290(5):F1065-73. PubMed ID: 16368743
[TBL] [Abstract][Full Text] [Related]
63. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
64. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
65. Endurance training-induced accumulation of muscle triglycerides is coupled to upregulation of stearoyl-CoA desaturase 1.
Dobrzyn P; Pyrkowska A; Jazurek M; Szymanski K; Langfort J; Dobrzyn A
J Appl Physiol (1985); 2010 Dec; 109(6):1653-61. PubMed ID: 20847127
[TBL] [Abstract][Full Text] [Related]
66. Metabolic reprogramming of the heart through stearoyl-CoA desaturase.
Dobrzyn P; Bednarski T; Dobrzyn A
Prog Lipid Res; 2015 Jan; 57():1-12. PubMed ID: 25482956
[TBL] [Abstract][Full Text] [Related]
67. Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma.
Ducheix S; Piccinin E; Peres C; Garcia-Irigoyen O; Bertrand-Michel J; Fouache A; Cariello M; Lobaccaro JM; Guillou H; Sabbà C; Ntambi JM; Moschetta A
Hepatol Commun; 2022 Oct; 6(10):2937-2949. PubMed ID: 35903850
[TBL] [Abstract][Full Text] [Related]
68. SCD1 Alters Long-Chain Fatty Acid (LCFA) Composition and Its Expression Is Directly Regulated by SREBP-1 and PPARγ 1 in Dairy Goat Mammary Cells.
Yao D; Luo J; He Q; Shi H; Li J; Wang H; Xu H; Chen Z; Yi Y; Loor JJ
J Cell Physiol; 2017 Mar; 232(3):635-649. PubMed ID: 27341271
[TBL] [Abstract][Full Text] [Related]
69. Role of stearoyl-CoA desaturase-1 in skin integrity and whole body energy balance.
Sampath H; Ntambi JM
J Biol Chem; 2014 Jan; 289(5):2482-8. PubMed ID: 24356954
[TBL] [Abstract][Full Text] [Related]
70. Modulation of SCD1 activity in hepatocyte cell lines: evaluation of genomic stability and proliferation.
de Lima Luna AC; Forti FL
Mol Cell Biochem; 2021 Sep; 476(9):3393-3405. PubMed ID: 33954906
[TBL] [Abstract][Full Text] [Related]
71. Regulation of stearoyl-CoA desaturases and role in metabolism.
Ntambi JM; Miyazaki M
Prog Lipid Res; 2004 Mar; 43(2):91-104. PubMed ID: 14654089
[TBL] [Abstract][Full Text] [Related]
72. The role of stearoyl-CoA desaturase in the regulation of cardiac metabolism.
Tabaczar S; Wołosiewicz M; Filip A; Olichwier A; Dobrzyń P
Postepy Biochem; 2018 Oct; 64(3):183-189. PubMed ID: 30656903
[TBL] [Abstract][Full Text] [Related]
73. Lipid metabolism: is liver X receptor (LXR) a regulator of adipocyte differentiation? Consequences of stearoyl-CoA desaturase activation by LXR.
Narce M; Poisson JP
Curr Opin Lipidol; 2004 Dec; 15(6):703-6. PubMed ID: 15529031
[No Abstract] [Full Text] [Related]
74. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
75. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
76. Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death.
Tesfay L; Paul BT; Konstorum A; Deng Z; Cox AO; Lee J; Furdui CM; Hegde P; Torti FM; Torti SV
Cancer Res; 2019 Oct; 79(20):5355-5366. PubMed ID: 31270077
[TBL] [Abstract][Full Text] [Related]
77. Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice.
Fritz V; Benfodda Z; Rodier G; Henriquet C; Iborra F; Avancès C; Allory Y; de la Taille A; Culine S; Blancou H; Cristol JP; Michel F; Sardet C; Fajas L
Mol Cancer Ther; 2010 Jun; 9(6):1740-54. PubMed ID: 20530718
[TBL] [Abstract][Full Text] [Related]
78. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
79. SCD1 is nutritionally and spatially regulated in the intestine and influences systemic postprandial lipid homeostasis and gut-liver crosstalk.
Burchat N; Akal T; Ntambi JM; Trivedi N; Suresh R; Sampath H
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Sep; 1867(9):159195. PubMed ID: 35718096
[TBL] [Abstract][Full Text] [Related]
80. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
